Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-25T20:10:06.735Z Has data issue: false hasContentIssue false

Anticholinergic Anti-Parkinson Medication for Neuroleptic-induced Extrapyramidal Side Effects

Published online by Cambridge University Press:  29 January 2018

Som D. Soni
Affiliation:
Prestwich Hospital, Manchester M25 8BL
D. A. W. Johnson
Affiliation:
Withington Hospital, Manchester
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

References

Altamura, A. C. et al. (1983) Italian Society of Biological Psychiatry. In Disipal in the Neuroleptic Syndrome, West Byfleet, Surrey: Brocades (Great Britain).Google Scholar
Bamrah, J. S., Kumar, V., Krska, J. & Soni, S. D. (1986) Interaction between procyclidine and neuroleptic drugs: some pharmacological and clinical aspects. British Journal of Psychiatry (in press).CrossRefGoogle Scholar
Johnson, D. A. W. (1985) Antipsychotic medication: Clinical guidelines for maintenance therapy. Journal of Clinical Psychiatry, 5, 615.Google Scholar
Lader, M. (1980) Introduction to Psychopharmacology. A ‘Scope’ Publication. Kalamazoo, Michigan: Upjohn Company.Google Scholar
Shader, R. I. Greenblatt, D. J. (1971) Uses and toxicity of bellandonna alkaloids and synthetic anticholinergics. Seminars in Psychiatry, 3, 449–76.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.